Florham Park counsel Jodi Sydell Rosenzweig published an article in the New Jersey Defense Newsletter titled, “In Re: Accutane Litigation and Multicounty Litigation: It’s Time to Cut to the Chase.” In the article, Jodi discusses a recent Accutane Multicounty Litigation decision in which the New Jersey Law Division held Accutane’s post-April 2002 warnings adequate as a matter of law and granted summary judgment to the manufacturer of the medication. The Court also clarified New Jersey law on the presumption of adequacy afforded to FDA-approved prescription drug warnings. The opinion applies to both New Jersey plaintiffs and plaintiffs who reside in jurisdictions with similar product liability laws.

Jodi reports the Accutane opinion shows that with proper case management, the courts can weed out meritless failure-to-warn claims in multicounty litigation sooner rather than later, saving the time, expense and resources of the parties, counsel and courts.

Source: New Jersey Defense Newsletter